Silve Vicent
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Tumor Organoids Grown in Mixed-Composition Hydrogels Recapitulate the Plasticity of Pancreatic Cancers.
Journal: Gels (Basel, Switzerland)
Published: June 30, 2025
Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma.
Journal: Cancer cell
Published: June 18, 2025
To be or not to be (a biliary cancer): RAS (signalling) is the question.
Journal: Gut
Published: June 10, 2025
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.
Journal: Signal transduction and targeted therapy
Published: October 10, 2024
GeNNius: an ultrafast drug-target interaction inference method based on graph neural networks.
Journal: Bioinformatics (Oxford, England)
Published: June 19, 2023
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.
Journal: Nature reviews. Gastroenterology & hepatology
Published: December 20, 2022
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Journal: Nature communications
Published: December 13, 2022
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 05, 2022
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 14, 2022
Last Updated: 09/26/2026